CD4 and neoplasm: Specifically, within the CD4+ T cell subpopulation, METTLE3 was found to be negatively correlated with Th2 and Th17 cells, which regulate inflammatory responses, while it was positively correlated with Th1 and Tfh cells, known for their crucial role in tumor immunotherapy.